PDPL Intraday Analysis...

PDPL Share Price

Open 18.20 Change Price %
High 18.80 1 Day 0.20 1.08
Low 17.50 1 Week -0.65 -3.37
Close 18.65 1 Month 0.80 4.48
Volume 13970 1 Year -9.95 -34.79
52 Week High 32.00
52 Week Low 16.65
PDPL Important Levels
Resistance 2 19.86
Resistance 1 19.36
Pivot 18.32
Support 1 17.94
Support 2 17.44
NSE INDIA Most Active Stocks
JPASSOCIAT 19.30 4.04%
RCOM 20.95 6.08%
SUZLON 17.00 1.49%
SOUTHBANK 31.05 -1.27%
UNITECH 7.35 0.00%
GMRINFRA 17.50 -1.96%
JPPOWER 7.35 -4.55%
DIVISLAB 990.90 5.10%
ADANIPOWER 32.35 0.00%
HUDCO 90.95 1.68%
More..
NSE INDIA Top Gainers Stocks
POCHIRAJU 7.20 20.00%
ITI 122.40 20.00%
ITI 122.40 20.00%
PALREDTEC 113.40 20.00%
GOKEX 114.10 19.98%
SMSPHARMA 110.25 19.97%
TARMAT 44.15 19.97%
ORCHIDPHAR 21.35 19.94%
VICEROY 21.70 19.89%
OMMETALS 79.50 17.87%
More..
NSE INDIA Top Losers Stocks
YESBANK 377.05 -79.95%
LASA 147.20 -24.90%
NAKODA 0.30 -14.29%
VASWANI 20.70 -10.00%
DQE 16.70 -8.99%
HIRECT 130.55 -8.87%
PRAKASHCON 4.15 -8.79%
TVVISION 155.40 -8.67%
IOLCP 51.55 -8.60%
INDOTECH 235.20 -8.34%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 4
As on 21st Sep 2017 PDPL Share Price closed @ 18.65 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 23.82 & Sell for SHORT-TERM with Stoploss of 20.60 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for September
1st Target up-side 20.66
2nd Target up-side 23.04
3rd Target up-side 25.43
1st Target down-side 13.84
2nd Target down-side 11.46
3rd Target down-side 9.07
PDPL Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 45.71 Sideways
MFI (14) MFI is 70.07 Sideways
CCI (20) CCI is -33.56 Sideways
WILLIAM %R (14) William %R is -60.40 Sideways
ADX (14) ADX is 17.91 Range Bound
PSAR Stoploss For Short Sell 21.55
10 Day Avg Volume Traded 5.77 % More then 10 Day Average Volume
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.